Industry Insight
Information, Observation & Analysis
Approximately one million cases of shingles are reported annually in the U.S., and half of individuals over age 85 years are likely to develop shingles. The need for a vaccine that can provide protective immunity against shingles and PHN in older at-risk adults is clear.
Considered by many to be merely cosmetic, this disorder may convince some to take it much more seriously after learning the facts.
The growing threat of this life-threatening disease to unborn children has spurred numerous research efforts to prevent and treat it.
Many years after the first products were introduced in the late 1990s, the need for fibrin sealants continues to increase.
Antibiotics are the most commonly prescribed drugs worldwide. But now, widespread antimicrobial resistance caused by environments, hosts and overmedication may soon be the demise of these "wonder drugs."
What are the true causes of the obesity epidemic that now affects more than one-third of people globally? And, do the measures thought to prevent obesity really work?
While support and resources are accessible to kids with Autism and their parents, families must prepare for children reaching adulthood, when resource availability changes and depends on a number of factors.
Studies are shedding light on this long-misunderstood and devastating condition that may soon have approved treatments to help prolong cancer patients’ lives.
HBV infection is still widely prevalent globally, but eradication could be achieved through efforts to raise awareness and find cures for the disease.
With staggering growth in the number of people addicted to and dying from opioids, government, the medical community and recovery programs are working to turn the tide.
This pervasive little-understood illness is finally getting the notice it deserves, with current attention focusing on better understanding and prevention.
The U.S. market for IVIG continues to grow well over 5 percent annually. What is driving the market demand?